Skip to main content
ONCO logo

ONCO · Onconetix, Inc. · Shareholders & Ownership

Track ONCO — free
$7.25 At close · Nov 6
Market Cap
$2.93M
Shares
394,911
Volume · Nov 6 763.44K Avg daily vol (3M) —

Every disclosed holder of ONCO in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns ONCO

13F quarter Sep 30, 2026, combined view: filers that have not filed yet carry their Jun 30, 2026 positions
Holder group Shares % Out
Institutional (13F) 8,094 2.05%
Insiders (Forms 3, 4, 5) 580 0.15%
13D/G-only blocks 41,962 10.63%
Remaining 344,275 87.18%
Registered funds (N-PORT, not summed) 2,264 0.57%

Shares outstanding: 394,911, the issuer's latest cover-page count restated onto today's split basis.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of ONCO

# Holder Shares
1
Keystone Capital Partners, LLC
13G CIK 1865973 · Unknown · Sep 30, 2026
Rule 13d-1(c), passive investor
41,930
2
HRT FINANCIAL LP
13F CIK 1475597 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
5,140
2.1
HRT FINANCIAL LP
Insider CIK 1475597 · Apr 21, 2026
10% Owner, issuer-wide, not summed
336
3
Fidelity Extended Market Index Fund
Fund S000006021 · Registered fund · Aug 31, 2026
Fidelity Concord Street Trust, not summed
2,264
4
StoneX Group Inc.
13F CIK 913760 · Unknown · Sep 30, 2026
1,541
5
XTX Topco Ltd
13F CIK 1828301 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
1,355
6
Altos Venture AG
13D CIK 2006260 · Unknown · Jul 14, 2025
Item 4 purpose: Passive investment
not summed
546
6.1
Altos Venture AG
Insider CIK 2006260 · Jul 14, 2025
10% Owner, issuer-wide
546
7
SBI Securities Co., Ltd.
13F CIK 1851815 · Non-US institution · Sep 30, 2026
31
8
Ralph Schiess
13D CIK 2006201 · Unknown · Jan 2, 2025
Item 4 purpose: Other
not summed
16
8.1
Schiess Ralph
Insider CIK 2006201 · Dec 20, 2024
Interim CEO, CSO, issuer-wide
16
9
Tower Research Capital LLC (TRC)
13F CIK 1533421 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
15
10
Christian Bruhlmann
13D CIK 2006197 · Unknown · Jan 2, 2025
Item 4 purpose: Other
not summed
14
10.1
Bruhlmann Christian
Insider CIK 2006197 · Dec 20, 2024
Chief Strategy Officer, issuer-wide
14
11
Scablis AG
13G CIK 2038013 · Unknown · Sep 24, 2024
Rule 13d-1(c), passive investor, unconfirmed, last confirmed Sep 24, 2024
14
12
New Horizon Health Limited
13G CIK 2036876 · Unknown · Sep 24, 2024
Rule 13d-1(c), passive investor, unconfirmed, last confirmed Sep 24, 2024
13
13
HOLLENCREST CAPITAL MANAGEMENT
13F CIK 1161722 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
10
14
Zurcher Kantonalbank (Zurich Cantonalbank)
13G CIK 1368163 · Non-US institution · Dec 24, 2024
Rule 13d-1(d), exempt investor
5
15
MORGAN STANLEY
13F CIK 895421 · Holding company · Jun 30, 2026
carried, not yet filed for the newest quarter
2
16
Meier Thomas
Insider CIK 2010924 · Aug 15, 2025
Director, issuer-wide
1
17
Oakley Andrew John
Insider CIK 2059152 · Aug 15, 2025
Director, issuer-wide
1
18
Ramdeen Timothy R.
Insider CIK 1962363 · Aug 15, 2025
Director, issuer-wide
1
19
Tarsh Simon
Insider CIK 1943931 · Aug 15, 2025
Director, issuer-wide
1

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1782107 CUSIP 68237Q401 13F (30d) 2 filings 2 filers Visit website Investor relations